23andMe gains after CEO Wojcicki makes revised $2.94/share offer with CVR
Me (ME) rose 3% after its CEO Anne Wojcicki made a non-binding revised offer of $2.94 a share for the genetic testing company ...
HFRO: Oversubscribed Tender Offer, Still A Massive -55% Discount To NAV
HFRO is a CEF which holds very illiquid investments, most being Level 3 assets. Learn more about HFRO CEF and its Series B ...
A10 Networks Shares Drop After Offering of Convertible Notes Prices
A10 Networks' shares were sharply lower after the technology company priced a roughly $200 million offering of convertible debt. In morning trading, the security-and-infrastructure-solutions company's ...
Beam Therapeutics Shares Drop After $500M Offering Prices
Beam Therapeutics shares were 14% lower, at $24.60, after the company priced an underwritten offering with proceeds of $500 million. The biotechnology company said it is offering 16.2 million shares ...